日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Systemic Steroid Treatment for Imatinib-Associated Severe Skin Rash in Patients with Gastrointestinal Stromal Tumor: A Phase II Study

全身性类固醇治疗伊马替尼相关严重皮疹治疗胃肠道间质瘤患者：一项 II 期研究

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2019-0953
Kim, Eo Jin; Ryu, Min-Hee; Park, Sook Ryun; Beck, Mo Youl; Lee, Woo Jin; Lee, Mi Woo; Kang, Yoon-Koo
发表日期：2020
文献求助 收藏

Phase II Trial of Continuous Regorafenib Dosing in Patients with Gastrointestinal Stromal Tumors After Failure of Imatinib and Sunitinib

伊马替尼和舒尼替尼治疗失败后，瑞戈非尼持续给药治疗胃肠道间质瘤患者的II期试验

期刊:Oncologist
影响因子:4.2
doi:10.1634/theoncologist.2019-0033
Kim, Jae-Joon; Ryu, Min-Hee; Yoo, Changhoon; Beck, Mo Youl; Ma, Jung Eun; Kang, Yoon-Koo
发表日期：2019
文献求助 收藏

Severe Imatinib-Associated Skin Rash in Gastrointestinal Stromal Tumor Patients: Management and Clinical Implications

胃肠道间质瘤患者伊马替尼相关严重皮疹：管理和临床意义

期刊:Cancer Research and Treatment
影响因子:3.8
doi:10.4143/crt.2015.017
Park, Sook Ryun; Ryu, Min-Hee; Ryoo, Baek-Yeol; Beck, Mo Youl; Lee, In Soon; Choi, Mi Jung; Lee, Mi Woo; Kang, Yoon-Koo
发表日期：2016
文献求助 收藏

Imatinib plasma monitoring-guided dose modification for managing imatinib-related toxicities in gastrointestinal stromal tumor patients

伊马替尼血浆监测指导下的剂量调整用于管理胃肠道间质瘤患者伊马替尼相关毒性

期刊:Journal of Korean Medical Science
影响因子:2.3
doi:10.3346/jkms.2013.28.8.1248
Yoon, Shinkyo; Ryu, Min-Hee; Yoo, Changhoon; Beck, Mo Youl; Ryoo, Baek-Yeol; Kang, Yoon-Koo
毒理研究
发表日期：2013
文献求助 收藏